Orris

Write etiopathogenesis and complication of Liver cirrhosis. (Long Answer Question)

Reading File
Finding Sources
Finding Sources
Searching PubMed

cirrhosis AND complications

Searching the Web

Merck Manual cirrhosis etiology pathogenesis complications

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading Web Page

https://www.merckmanuals.com/professional/hepatic-and-biliar…

Liver Cirrhosis

Definition: Cirrhosis is a diffuse, irreversible structural disease of the liver characterized by:
  1. Diffuse hepatic fibrosis
  2. Formation of regenerative nodules
  3. Distortion of normal hepatic and vascular architecture
This produces two main consequences: portal hypertension and hepatocellular failure.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 1403.

Etiopathogenesis

A. Etiology

Cirrhosis is the common end stage of many chronic liver diseases.

1. Alcohol-related liver disease

  • Chronic heavy alcohol consumption causes fatty liver, alcoholic hepatitis, progressive fibrosis, and cirrhosis.
  • Alcohol may also accelerate fibrosis caused by hepatitis C, iron overload, and metabolic dysfunction-associated steatotic liver disease.
  • It classically causes micronodular cirrhosis initially; later it may become mixed micro- and macronodular.

2. Chronic viral hepatitis

  • Chronic hepatitis B
  • Chronic hepatitis C
  • Chronic hepatitis D infection in association with hepatitis B
Persistent viral inflammation and hepatocyte injury lead to progressive fibrosis.

3. Metabolic dysfunction-associated steatotic liver disease

  • Metabolic dysfunction-associated steatohepatitis (MASH), previously called NASH
  • Associated with obesity, insulin resistance, type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome.

4. Autoimmune and cholestatic liver disease

  • Autoimmune hepatitis
  • Primary biliary cholangitis
  • Primary sclerosing cholangitis
  • Autoimmune cholangiopathy
  • Long-standing extrahepatic biliary obstruction, such as biliary stricture, stone disease, or biliary atresia

5. Inherited and metabolic disorders

  • Hereditary hemochromatosis
  • Wilson disease
  • Alpha-1 antitrypsin deficiency
  • Cystic fibrosis-associated liver disease
  • Glycogen storage disorders and other rare metabolic conditions

6. Vascular and cardiac causes

  • Chronic right-sided heart failure causing congestive hepatopathy or cardiac cirrhosis
  • Constrictive pericarditis
  • Budd-Chiari syndrome
  • Chronic portal vein abnormalities

7. Drugs, toxins, and infections

  • Long-term hepatotoxic drug exposure, for example methotrexate or amiodarone
  • Chronic exposure to certain toxins
  • Schistosomiasis, which commonly causes portal fibrosis and portal hypertension, though hepatocellular cirrhosis may be less prominent

8. Cryptogenic cirrhosis

  • Cirrhosis in which no cause is identified after evaluation.
  • Many cases previously labeled cryptogenic are now considered to represent “burnt-out” MASH.
The major etiologic categories include alcohol, chronic viral hepatitis, autoimmune hepatitis, MASH, cholestatic disease, cardiac disease, and inherited metabolic disorders. Harrison’s Principles of Internal Medicine, 22nd ed., p. 1363.

B. Pathogenesis

1. Persistent liver injury

Regardless of cause, repeated or persistent hepatocyte injury occurs due to alcohol, viral infection, fat-induced lipotoxicity, cholestasis, immune injury, iron or copper overload, or venous congestion.
This causes:
  • Hepatocyte necrosis and apoptosis
  • Inflammation
  • Release of cytokines, reactive oxygen species, and profibrotic mediators
  • Kupffer-cell activation

2. Activation of hepatic stellate cells

The central event in hepatic fibrosis is activation of hepatic stellate cells in the space of Disse.
Normally, stellate cells:
  • Store vitamin A
  • Remain quiescent
  • Support sinusoidal structure
Following chronic injury, cytokines such as transforming growth factor-beta and platelet-derived growth factor activate stellate cells. They transform into myofibroblast-like cells, which:
  • Proliferate and migrate to sites of damage
  • Contract and increase intrahepatic vascular resistance
  • Synthesize collagen and other extracellular matrix components
  • Reduce matrix degradation
Portal fibroblasts also contribute, particularly in cholestatic or biliary injury. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 1403.

3. Fibrosis and bridging fibrosis

Excess extracellular matrix accumulates in the space of Disse and hepatic lobules, producing:
  • Perisinusoidal fibrosis
  • Periportal fibrosis
  • Centrilobular fibrosis
  • Portal-to-portal bridging fibrosis
  • Portal-to-central bridging fibrosis
  • Central-to-central bridging fibrosis
The fibrosis joins vascular structures that are normally separate, thereby disrupting normal hepatic blood flow.

4. Regeneration and nodule formation

The injured liver attempts regeneration. Surviving hepatocytes proliferate, but the regenerative tissue is surrounded and subdivided by fibrous septa.
This results in regenerative nodules:
  • Small nodules: micronodular cirrhosis
  • Larger nodules: macronodular cirrhosis
  • Mixed nodular pattern may occur in advanced disease

5. Distortion of vascular architecture

Fibrous septa, regenerative nodules, sinusoidal capillarization, and stellate-cell contraction distort the hepatic vascular bed. This increases resistance to portal venous flow and causes portal hypertension.
Portal hypertension leads to:
  • Formation of portosystemic collaterals
  • Varices
  • Splenomegaly and hypersplenism
  • Ascites

6. Loss of hepatocyte function

Progressive loss of functioning hepatocyte mass causes impaired:
  • Bilirubin conjugation and excretion
  • Albumin synthesis
  • Clotting-factor synthesis
  • Detoxification of ammonia and other neurotoxins
  • Drug metabolism
  • Immune function
Thus, cirrhosis produces both portal hypertension and hepatic failure. Portal hypertension causes ascites and variceal bleeding, while hepatocellular failure causes jaundice, hypoalbuminemia, coagulopathy, and contributes to encephalopathy. Harrison’s Principles of Internal Medicine, 22nd ed., p. 1363.

Complications of Cirrhosis

The occurrence of ascites, variceal bleeding, or hepatic encephalopathy indicates decompensated cirrhosis. Harrison’s Principles of Internal Medicine, 22nd ed., p. 1363.

A. Complications due to portal hypertension

1. Ascites

Accumulation of fluid in the peritoneal cavity due to:
  • Increased portal venous hydrostatic pressure
  • Splanchnic vasodilatation
  • Renal sodium and water retention
  • Hypoalbuminemia
It may cause abdominal distension, early satiety, dyspnea, umbilical hernia, and pleural effusion.

2. Varices and variceal hemorrhage

Portosystemic collateral formation produces:
  • Esophageal varices
  • Gastric varices
  • Rectal varices
  • Caput medusae
Rupture of esophageal or gastric varices may cause massive hematemesis, melena, shock, and death.

3. Portal hypertensive gastropathy

Congestive mucosal changes in the stomach can cause chronic blood loss or acute gastrointestinal bleeding.

4. Splenomegaly and hypersplenism

Congestive splenomegaly causes excessive sequestration and destruction of blood cells, resulting in:
  • Thrombocytopenia
  • Leukopenia
  • Anemia

5. Spontaneous bacterial peritonitis

Infection of ascitic fluid without an evident surgically treatable intra-abdominal source. It commonly presents with fever, abdominal pain, encephalopathy, hypotension, renal dysfunction, or deterioration of ascites.

6. Hepatorenal syndrome

Functional renal failure in advanced cirrhosis, particularly with ascites. Marked splanchnic vasodilatation reduces effective arterial blood volume, leading to renal vasoconstriction and reduced glomerular filtration.

7. Hepatic hydrothorax

Transudative pleural effusion, usually right-sided, caused by movement of ascitic fluid across diaphragmatic defects.

8. Hepatopulmonary syndrome and portopulmonary hypertension

  • Hepatopulmonary syndrome: intrapulmonary vascular dilatation leading to hypoxemia.
  • Portopulmonary hypertension: pulmonary arterial hypertension associated with portal hypertension.
The Merck Manual summary lists variceal bleeding, ascites, thrombocytopenia, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatopulmonary syndrome, and portopulmonary hypertension among key complications of portal hypertension.

B. Complications due to hepatocellular failure

1. Jaundice and cholestasis

Failure of bilirubin excretion causes jaundice, dark urine, pruritus, and sometimes fat malabsorption.

2. Hypoalbuminemia

Reduced albumin synthesis leads to:
  • Peripheral edema
  • Worsening ascites
  • Muscle wasting
  • Reduced transport of protein-bound substances

3. Coagulopathy and bleeding tendency

Reduced synthesis of clotting factors causes prolonged prothrombin time or INR and an increased tendency to bleed. Thrombocytopenia due to hypersplenism often worsens this.
However, cirrhosis can also predispose to thrombosis, including portal-vein thrombosis, because both procoagulant and anticoagulant factors are reduced.

4. Hepatic encephalopathy

Neuropsychiatric dysfunction due to inadequate hepatic detoxification and portosystemic shunting. Ammonia and other gut-derived neurotoxins contribute.
Features include:
  • Sleep disturbance
  • Personality or behavioral change
  • Confusion
  • Asterixis
  • Drowsiness
  • Coma in severe cases
Common precipitating factors are gastrointestinal bleeding, constipation, infection, dehydration, electrolyte disturbances, sedatives, renal failure, and excess dietary protein in susceptible patients.

5. Malnutrition and sarcopenia

Cirrhosis causes anorexia, early satiety, malabsorption, altered metabolism, and muscle protein breakdown, leading to wasting and reduced immunity.

6. Endocrine and sexual dysfunction

  • Gynecomastia
  • Testicular atrophy
  • Loss of axillary and pubic hair
  • Impotence and reduced libido in males
  • Menstrual irregularity and infertility in females
These result from altered metabolism of sex hormones and chronic systemic illness.

7. Immune dysfunction and infections

Patients have impaired innate and adaptive immunity, predisposing them to:
  • Spontaneous bacterial peritonitis
  • Pneumonia
  • Urinary tract infection
  • Bacteremia and sepsis

8. Acute-on-chronic liver failure

An acute insult, such as infection, alcohol-associated hepatitis, gastrointestinal bleeding, or drug injury, can precipitate rapid hepatic decompensation with extrahepatic organ failure.

C. Hepatocellular carcinoma

Cirrhosis is a major premalignant state. Continuous inflammation, cellular injury, regeneration, and genomic instability predispose to hepatocellular carcinoma (HCC).
HCC may occur in cirrhosis of almost any etiology, especially:
  • Chronic hepatitis B and C
  • Alcohol-related liver disease
  • MASH
  • Hemochromatosis
  • Primary biliary cholangitis
The Merck Manual review states that HCC can complicate cirrhosis from any cause, supporting routine surveillance in affected patients.

Summary flowchart

Chronic liver insult
→ hepatocyte injury and inflammation
→ activation of stellate cells
→ collagen deposition and fibrosis
→ bridging fibrosis
→ regenerative nodules plus distorted architecture
→ cirrhosis
→ portal hypertension + hepatocellular failure
→ ascites, varices and bleeding, splenomegaly, spontaneous bacterial peritonitis, hepatorenal syndrome, encephalopathy, jaundice, coagulopathy, malnutrition, infections, and hepatocellular carcinoma.
This is a shared conversation. Sign in to Orris to start your own chat.